Polyrizon Ltd. - (PLRZ) closed at $8.96 on October 26, 2026, up 2.7% from the previous close, on volume of 15,375 shares (30-day average 27,105).
Data as of October 26, 2026.
Polyrizon Completes Enrollment in 120-Patient U.S. Trial of NASARIX Allergy Blocker
TipRanks (Tue, 27-Oct 8:57 AM ET)
Globe Newswire (Tue, 27-Oct 8:16 AM ET)
Globe Newswire (Mon, 5-Oct 7:32 AM ET)
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Globe Newswire (Tue, 22-Sep 8:33 AM ET)
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Globe Newswire (Fri, 4-Sep 11:58 AM ET)
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Globe Newswire (Thu, 3-Sep 8:50 AM ET)
Polyrizon Completes All Five U.S. Site Contracts for NASARIX First-in-Human Allergy Study
Globe Newswire (Wed, 2-Sep 7:32 AM ET)
Polyrizon Completes Clinical Site Network for NASARIX Study and Advances Toward Patient Enrollment
Globe Newswire (Thu, 20-Aug 9:30 AM ET)
Market Chameleon (Wed, 4-Feb 3:03 AM ET)
PL-14 Outperforms HPMC: Polyrizon’s Pre-Clinical Study Shows Markedly Superior Allergen Blocking
Market Chameleon (Mon, 5-Jan 4:27 AM ET)
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Polyrizon Ltd. - trades on the NASDAQ stock market under the symbol PLRZ.
As of October 27, 2026, PLRZ stock price declined to $8.73 with 2,902 million shares trading.
PLRZ has a beta of 0.82, meaning it tends to be less sensitive to market movements. PLRZ has a correlation of 0.00 to the broad based SPY ETF.
PLRZ has a market cap of $21.20 million. This is considered a Sub-Micro Cap stock.
PLRZ has outperformed the market in the last year with a return of +36.0%, while the SPY ETF gained +14.8%. However, in the most recent history, PLRZ shares have underperformed the stock market with its stock returning -40.5% in the last 3 month period and -3.5% for the last 2 week period, while SPY has returned +4.4% and -1.1%, respectively.
PLRZ support price is $8.14 and resistance is $9.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLRZ shares will trade within this expected range on the day.
